nitazoxanide: Clinical Trials

56 trials of nitazoxanide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

29 completed, 9 unknown, 6 terminated, 5 recruiting. 56 Phase 2, 17 Phase 3, 6 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 256Completed 29, Unknown 9, Terminated 6, Recruiting 5, Withdrawn 4, Not yet recruiting 3
Phase 317Completed 7, Unknown 5, Terminated 2, Not yet recruiting 1, Recruiting 1, Withdrawn 1
Phase 16Completed 2, Recruiting 2, Unknown 1, Withdrawn 1

Follow nitazoxanide: new trials by email Literature Review of nitazoxanide trials Research Report on nitazoxanide

Trials (filtered) newest first · largest first

All 56 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Nitazoxanide in Spontaneous Bacterial Peritonitis
Nitazoxanide (NTZ), Placebo - SBP - Spontaneous Bacterial Peritonitis
Phase 1 / Phase 2RecruitingTanta University602026-10-252026-10-30
Nitazoxanide as Adjunct Therapy in Mild-to-Moderate Ulcerative Colitis
Nitazoxanide (NTZ) - Ulcerative Colitis (UC)
Phase 2 / Phase 3RecruitingTanta University442026-10-252026-11-09
Phase 2 Study of 500 mg BID NTZ on Top of Standard of Care in Patients With Acute Decompensation of Liver Cirrhosis at High Risk of Progression to Acute-on-Chronic Liver Failure or Established Acute-on-Chronic Liver Failure
NTZ 500mg BID on top of SOC - Acute Decompensation of Liver Cirrhosis, Established Acute-on-Chronic Liver Failure
Phase 2Not yet recruitingGenfit162026-10-012026-07-09
A Clinical Trial Evaluating Fecal Microbiota Transplantation (FMT) in Adolescents With ADHD
Fecal Microbiota Transplant (FMT), Nitazoxanide 500mg BID, Vancomycin 250mg BID - ADHD, ADHD - Attention Deficit Disorder With Hyperactivity
Phase 2Not yet recruitingUniversity of Calgary642026-08-312026-09-10
Nitazoxanide in Patients With Ulcerative Colitis
Mesalamine, Nitazoxanide - Ulcerative Colitis
Phase 2RecruitingAlexandria University702025-05-302025-06-27
Nitazoxanide vs Metronidazole for Entamoeba Diarrhea in Children
Nitazoxanide, Metronidazole - Entamoeba Histolytica Diarrhea
Phase 2CompletedUniversity of Child Health Sciences and Children's Hospital, Lahore902024-04-022026-08-27
Nitazoxanide as Adjuvant Therapy in Type 2 Diabetes Mellitus
Nitazoxanide - Diabetes Mellitus, Type 2
Phase 2UnknownTanta University702023-10-012023-08-25
Combination Therapy Between Doxycycline, Pentoxifylline, and Nitazoxanide in Sexually Active Men
Doxycyclin, Pentoxifylline, Nitazoxanide 500Mg Oral Tablet - Sexually Transmitted Diseases
Phase 2 / Phase 3Not yet recruitingTanta University1002023-06-202023-06-12
Comparing the Efficacy of Nitazoxanide Versus Rifaximin in Adult Patients With Irritable Bowel Syndrome Without Constipation
Nitazoxanide 500Mg Oral Tablet, Rifaximin 550Mg Tab - Irritable Bowel Syndrome With Diarrhea
Phase 1 / Phase 2WithdrawnSadat City University2022-07-012025-07-14
Favipiravir +/- Nitazoxanide: Early Antivirals Combination Therapy in COVID-19
Favipiravir, Nitazoxanide, Nitazoxanide Placebo - Covid19
Phase 2CompletedCoordinación de Investigación en Salud, Mexico1202021-10-122023-03-24
Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV)
Nirmatrelvir/ritonavir (e.g. PAXLOVID™), Nitazoxanide, Molnupiravir and nirmatrelvir/ritonavir (e.g. PAXLOVID™) - COVID-19
Phase 2RecruitingUniversity of Oxford38002021-09-302026-02-19
Early Treatment of Vulnerable Individuals With Non-Severe SARS-CoV-2 Infection
Nitazoxanide and Ciclésonide, Telmisartan 20Mg Oral Tablet, Paracetamol - Covid19, Covid19 Drug Treatment
Phase 2 / Phase 3UnknownANRS, Emerging Infectious Diseases6002021-04-122023-01-31
COVID-19 Prophylaxis South Africa (COVER HCW)
Nitazoxanide, Sofosbuvir/Daclatasvir - Covid19, SARS-CoV Infection
Phase 2CompletedUniversity of Witwatersrand, South Africa19502020-12-082022-06-07
A Triple Combination Antiviral Coronavirus Therapy (TriACT) for COVID-19
Nitazoxanide, Placebo Nitazoxanide, Ribavirin - SARS-CoV Infection, Covid19
Phase 2TerminatedRutgers, The State University of New Jersey72020-12-022022-05-05
The Nitazoxanide Plus Atazanavir for COVID-19 Study
Nitazoxanide and atazanavir/ritonavir, Standard of Care - Covid-19
Phase 2TerminatedObafemi Awolowo University572020-10-092022-03-02
Four Different Experimental Drug Regimens to Standard of Care for the Treatment of Symptomatic Outpatients With COVID-19
Paracetamol, Artesunate-amodiaquine, Pyronaridine-artesunate - COVID-19
Phase 2CompletedShin Poong Pharmaceutical Co. Ltd.1922020-09-032025-07-28
Catalysing the Containment of COVID-19
Nitazoxanide, Placebo - COVID-19
Phase 2 / Phase 3TerminatedUniversity of Cape Town3222020-08-272022-08-16
AGILE (Early Phase Platform Trial for COVID-19)
CST-2: EIDD-2801, CST-2: Placebo, Nitazoxanide - Covid19
Phase 1 / Phase 2RecruitingUniversity of Liverpool6002020-07-032026-06-01
Efficacy and Safety of Nitazoxanide 600 mg to Treat Mild Ambulatory COVID-19 Patients
Nitazoxanide, Placebo - covid19
Phase 2 / Phase 3WithdrawnAzidus Brasil2020-07-012022-10-28
EAT-DUTA AndroCoV Trial
Dutasteride 0.5 mg, Azithromycin, Nitazoxanide - Covid19
Phase 2 / Phase 3CompletedCorpometria Institute1382020-06-302021-01-28

Showing 20 of 56. Sign in to see all of them.

Conditions studied

COVID-19 (17)  ·  Hepatitis C, Chronic (8)  ·  HIV Infections (5)  ·  Coronavirus Infections (4)  ·  Hepatitis C (4)  ·  Colitis, Ulcerative (3)  ·  Severe Acute Respiratory Syndrome (3)  ·  AIDS-Related Opportunistic Infections (2)  ·  Cryptosporidiosis (2)  ·  Gastroenteritis (2)  ·  Hepatic Encephalopathy (2)  ·  Influenza, Human (2)  ·  Rotavirus Infections (2)  ·  Acute-On-Chronic Liver Failure (1)  ·  Adenoviridae Infections (1)

Sponsors

Romark Laboratories L.C. (13)  ·  Tanta University (6)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (5)  ·  Azidus Brasil (2)  ·  Telethon Kids Institute (2)  ·  Universidade Federal do Rio de Janeiro (2)  ·  ANRS, Emerging Infectious Diseases (1)  ·  Ain Shams University (1)  ·  Alexandria University (1)  ·  Cairo University (1)  ·  Coordinación de Investigación en Salud, Mexico (1)  ·  Corpometria Institute (1)  ·  Genfit (1)  ·  Haydom Lutheran Hospital (1)  ·  Juan Macías (1)

Countries

Egypt (14)  ·  United States (12)  ·  South Africa (5)  ·  Brazil (4)  ·  Australia (2)  ·  Mexico (2)  ·  Pakistan (2)  ·  Thailand (2)  ·  Argentina (1)  ·  Burkina Faso (1)  ·  Canada (1)  ·  Guinea (1)  ·  Haiti (1)  ·  Laos (1)  ·  Nepal (1)

Top investigators

Asem Elfert, MD (4)  ·  Yehia El-Gohary, MD (3)  ·  Arthur Berman, DO (2)  ·  Ira Jacobson, MD (2)  ·  Mona Abu-Zekry, MD (2)  ·  Norman Gitlin, MD (2)  ·  Patricia RM Rocco, MD, PhD (2)  ·  Stephen Harrison, MD (2)  ·  Ahmed Aijaz, MD (1)  ·  Aijaz Ahmed, MD (1)  ·  Alejandra Ramirez Venegas, M.D. (1)  ·  Andy Goren, MD (1)  ·  Arnold L Lentnek, M.D. (1)  ·  Arturo Galindo Fraga, M.D. (1)

Results publications

PMID 34473343, PMID 16829296, PMID 23890273, PMID 24852376, PMID 26640956, PMID 29982218, PMID 30753384, PMID 32071052, PMID 33188747, PMID 33397457, PMID 33602926, PMID 34450619, PMID 34582462, PMID 34699618, PMID 35271729, PMID 35492335, PMID 35869526, PMID 36160134, PMID 36272432, PMID 36435798, PMID 36574985, PMID 36803992, PMID 36963502, PMID 37261117, PMID 37382971, PMID 37470445, PMID 37778363, PMID 38225598, PMID 38677300, PMID 39032770, PMID 39896880, PMID 40385586, PMID 40815384, PMID 41082886, PMID 41232946, PMID 41321979, PMID 41848748, PMID 42177030, PMID 42309304